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Background: The TGF-β signaling pathway is a fundamental pathway in the living cell, which plays a key role in
many central cellular processes. The complex and sometimes contradicting mechanisms by which TGF-β yields
phenotypic effects are not yet completely understood. In this study we investigated and compared the transcriptional
response profile of TGF-β1 stimulation in different cell types. For this purpose, extensive experiments are performed
and time-course microarray data are generated in human and mouse parenchymal liver cells, human mesenchymal
stromal cells and mouse hematopoietic progenitor cells at different time points. We applied a panel of bioinformatics
methods on our data to uncover common patterns in the dynamic gene expression response in respective cells.
Results: Our analysis revealed a quite variable and multifaceted transcriptional response profile of TGF-β1 stimulation,
which goes far beyond the well-characterized classical TGF-β1 signaling pathway. Nonetheless, we could identify
several commonly affected processes and signaling pathways across cell types and species. In addition our analysis
suggested an important role of the transcription factor EGR1, which appeared to have a conserved influence across
cell-types and species. Validation via an independent dataset on A549 lung adenocarcinoma cells largely confirmed our
findings. Network analysis suggested explanations, how TGF-β1 stimulation could lead to the observed effects.
Conclusions: The analysis of dynamical transcriptional response to TGF-β treatment experiments in different human
and murine cell systems revealed commonly affected biological processes and pathways, which could be linked to
TGF-β1 via network analysis. This helps to gain insights about TGF-β pathway activities in these cell systems and its
conserved interactions between the species and tissue types.
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The transforming growth factor-beta1 (TGF-β1) signaling
pathway is a fundamental pathway in the living cell, which
plays a role in many central cellular processes. The TGF-β
superfamily contains over 30 different proteins, such as
BMPs, Activins, Inhibins, and the TGF-β1 isoforms [1-3].
The pathway contributes to regulation of various cellular
processes, such as apoptosis, cell differentiation, cell growth* Correspondence: abnaof@bit.uni-bonn.de
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unless otherwise stated.as well as tumor suppression and immune regulation
processes [4].
There are three TGF-β isoforms (TGF-β1, TGF-β2,
TGF-β3) which have different physiological and patho-
logical effects on epithelial, endothelial, lymphatic, mye-
loid and mesenchymal tissues [5]. The TGF-β pathway is
one of the most studied pathways [6-10]. However, the
complex and sometimes contradicting mechanisms by
which TGF-β yields phenotypic effects is not yet com-
pletely understood [5]. The classical TGF-β1 pathway is
already well established since several years [7]. However,
the identification of alternative signaling pathways that
contain different receptors and Smad proteins has in-
creased the overall complexity of the TGF-β1 signalingLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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fied cartoon sketch comprising mainly Smads cascades
in the TGF-β1 signaling pathway.
In this study we investigated and compared down-
stream effects of TGF-β1 stimulation on the dynamical
response of gene expression in mouse and human in dif-
ferent cell and tissue types. Two types of mouse
hematopoietic progenitor cells were used: multipotent
progenitor (MPP) and dendritic cell (DC) committed
progenitors, referred to as common dendritic progenitor
(CDP) cells. CDP differentiate from MPP and give rise
to two types of DC: plasmacytoid DC (pDC) and con-
ventional DC (cDC). MPP and CDP were obtained from
bone marrow by in vitro culture with a specific cytokine
cocktail and FACS sorting [12,13]. Furthermore, we
employed human mesenchymal stromal cells (MSC),
which differentiate into osteocytes, chondrocytes or adi-
pocytes [14-16]. Finally, primary murine hepatocytes
(HPC) and immortalized human hepatocytes (human
HPC, HepG2) cells were used. We have taken these dif-
ferent cell types for three reasons: (i) All these cells are
highly responsive to TGF-β. (ii) The different cell types
reflect different degrees of differentiation. (iii) The differ-
ent cells show a variable response to TGF-β. While in
hepatocytes TGF-β induces apoptosis, multipotent pro-
genitors initiate a differentiation programme in response
to TGF-β.
Very little and vague information is known about the
detailed influence of TGF-β1 in these different cell sys-
tems. For example, TGF-β1 is known to be necessary for
MSC proliferation. It is essential for chondrogenic differ-
entiation. On the other hand, TGF-β1 participates in in-
hibition of adipogenic and osteogenic differentiation.
Furthermore, there are evidences, that TGF-β1 contrib-
utes to supporting myogenic differentiation of MSC
[17-19]. There are also evidences that the TGF-β path-
way play a role in the induction of cellular senescence
in MSC [20]. Although TGF-β1 triggers primary early
responses (e.g. Smad activation) and EMT in human
HPC (HepG2) cells, cell cycle arrest and apoptosis are
generally not promoted by TGF-β1 [21,22]. Further-
more, TGF-β1 is known to be crucial for development
of Langerhans cells, the cutaneous contingent of migra-
tory dendritic cells, both in vivo and in vitro and it evi-
dently contributes in accelerating their differentiation
and directing their subsets specification toward cDCs
[12,23-25].
We used a panel of bioinformatics methods, ranging
from statistical testing over functional and promoter se-
quence analysis to clustering for pattern discovery in our
gene expression time series data. Only one gene, the
SKI-like oncogene (Skil), was commonly found to be
differentially expressed (DE) in all cell types. Skil is a
component of the SMAD-pathway, which regulates cellgrowth and differentiation. Moreover, Smad7 that blocks
TGF-β receptor activity seems to play a major common
role, because it was identified as DE in most cell types.
Despite of the differences on the level of individual
genes we observed a conserved effect of TGF-β1 stimu-
lation on a number of biological processes and pathways.
Moreover, we could identify a few overrepresented tran-
scription factor binding sites, which were commonly
found in several cell types. Specifically EGR1 seems to
have major relevance for the transcriptional stimulation
response in mouse and human.
By analysis of an independent dataset on human A549
lung adenocarcinoma cells (CRL) from GEO (access No.
GSE17708) [26] we were able to reproduce a highly sig-
nificant proportion of the commonly identified biological
processes, pathways and transcriptional factors in our
datasets. Network analysis suggests explanations, how
TGF-β1 stimulation could lead to the observed effects.
Results and discussion
Time series transcriptome measurements
All cell types were treated with TGF-β in three bio-
logical replicates. TGF-β treatment concentrations were
optimized in each cell type to show a maximal effect.
Extracted RNA samples were hybridized to microarrays
(Affymetrix Gene 1.0 ST) for genome-wide transcrip-
tome analysis. Mouse progenitor cells and HepG2 cells
were measured at 6 successive time points, mouse pri-
mary HPC cells at 5, and human MSCs at 4 different
time points. Additional file 2: Table S1 gives an over-
view of our experiments and the measured time-points,
the “Methods” section gives details about cell cultures,
stimulation, RNA-isolation and array hybridization in
our experiments.
Differential gene expression
Transcriptional response is highly tissue specific on gene level
We employed the “betr” method [27] to quantify the
probability of differential expression of genes in whole
time-courses (see Methods). Using this approach we
were able to assess differential gene expression for each
gene in each cell type in a comparable manner. We con-
sidered a gene to have differential time-course expres-
sion (DE), if it had a probability of >99% and was at least
two-fold up- or down-regulated at one time point mini-
mum (Additional file 1: Figures S2 a & b, Additional
file 2: Tables S2 & S8).
The strongest stimulatory effect of TGF-β1 was ob-
served in CDP cells (614 genes). Eight out of these
genes in CDP are already known to play a role in the
TGF-β pathway (Tgfb3, Smad7, Thbs1, Tgfbr1, Smurf1,
Smad3, Smad6, Tgfbr2). In mouse HPC a significantly
lower number of DE genes were found compared to
other cell types.
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types. It is worth mentioning in this context that com-
parisons between mouse and human genes were done
on the basis of homologous genes (see Methods). Not
surprisingly, the found overlap was particularly high
among mouse hematopoietic progenitor cells (MPP and
CDP). These were 173 genes, which equals a harmonic
mean of above 41% of DE genes in both cell types
(Additional file 1: Figure S2 a). Only two of these genes,
namely Smad7 and Tgfbr1 are known to play a role in
the TGF-β pathway. Three genes (Lox, Pmepa1, Skil)
are found to be DE in all mouse cells (CDP, MPP and
HPC). Pmepa1 (Prostate Transmembrane Protein) is
known to interact with Smad and suppress the TGF-β
pathway [28,29]. Only the protein-coding gene Skil
(Ski-like-oncogene) that encodes a protein in the SMAD-
pathway [30,31] was found to have a DE time-course in all
cell types. In addition, the gene Smad7 was commonly
found in all cell types except mouse HPC cells. 18 genes
including ROR1, C10orf10, SMAD7, FSTL3, GADD45B,
JUNB, ZFP36, OLFM2, SPTLC3, ID1, LMCD1, SLC38A3,
GXYLT2, SKIL, HES1, RASGEF1B, CITED2 and PDGFA
were DE in all human cells (MSC, HepG2). The heatmaps
in Additional file 1: Figure S3 visualize patterns of tem-
poral behavior for particular groups of genes. Here again
we see similarity in gene expressions between mouse
dendritic cells.
These findings on one hand stress the similarity of the
transcriptional response in MPP and CDP, which is not
very surprising given the fact that these cells were both
derived from bone marrow. On the other hand they
highlight that TGF-β1 treatment affects by far not only
genes within the canonical TGF-β1 pathway, but leads
to a large number of diverse secondary downstream ef-
fects, which are only partially overlapping across differ-
ent cell types. In other words there is a high tissue
specificity of the transcriptional TGF-β stimulation re-
sponse on the level of individual genes.
TGF-β1 pathway genes react time-dependant and tissue-specific
We had a closer look at genes, which are known to play
a role in the TGF-β1 pathway, such as Bmp(s), Smad(s)
and Id(s). In Figure 1 the log2 fold changes of 17 genes
involved in the TGF-β1 pathway, which are DE in at
least one cell type, are depicted. It can be noticed that
almost all genes show time-dependant transcriptional ef-
fects. These effects are distinct between early and later
time points, with moderate activities until 4 h and
mostly higher activities at late times. It can also be
noticed that cells of similar origin are more alike. For ex-
ample, Bmp2, Bmp4, Bmp6, Cdkn2b and Comp are dys-
regulated (i.e. significantly differ from 0 level according
to “betr”) only in human and not in mouse tissues. Fs1 is
similar to these genes, but also shows activity in mouseHPC. Id1 in human cells is up-regulated at earlier time
points and a down-regulated after 4 h. Inhba shows ac-
tivity only in MSC cells where its expression after 1 hour
constantly increases. Smad3, Smad6 and Smad7 reveal
similar time courses in mouse MPP and CDP cells and
in human MSCs. Smad3 is increasingly down-regulated
over time and the other two genes are always up-
regulated. Smurf1 is always over-expressed and shows a
curve that is opposite to Smad3, Smad6 and Smad7.
Tgfb3 is over-expressed at later time points in MPP and
CDP cells and shows almost no activity in the other cell
types. Thbs1 is highly active in all cell types. However,
while it is underrepresented in MPP and CDP, it shows el-
evated expression in mouse and human HPC. Tgfbr1 and
Tgfbr2 behave similar, in particular in mouse progenitor
cells, where Tgfbr2 is less up-regulated than Tgfbr1.
Time point specific analysis confirms highly tissue specific
expression changes on gene expression level
In order to cross-validate our previous analysis, which con-
siders time series as a whole, we conducted also a time-point
specific analysis of differential gene expression using lin-
ear models for microarray data (Limma). For this purpose
we compared the gene expression at 4 hours after stimula-
tion to the initial expression at time point 0. The time
period of 4 hours was chosen because at least short-time
relevant effects are expected in all cell types after this period.
In the context of this time point specific analysis of
transcriptional effects we considered a gene to be differen-
tially expressed (DE) in a given cell type, if FDRBH < 0.01
and the absolute fold changes was (logFC) > 1. The
overlap analysis of DE genes at 4 h agrees with the
time-course analysis. There are no or very few genes in
common between the different cell types except in the case
of mouse dendritic cells (Additional file 1: Figure S5 A).
Moreover, the direction of regulation (up or down) differs
between cell types (Additional file 2: Table S9).
The heatmap in Additional file 1: Figure S4 depicts the
log fold changes of all genes, which are DE in at least
one cell type. The plot indicates two gene sets, which
clearly show a similar behavior in mouse MPP and CDP
cell types. The first set contains 36 genes that are over-
expressed. The other set (42 genes) is under-expressed.
Interestingly, the 36 genes being up-regulated in MPP
and CDP cells are not regulated by TGF-β1 in other cell
types. Although not DE genes in every cell type, the
genes Smad7, Pmepa1 (beside the gene Skil) seem to be
up-regulated in all the cells. The rest of the genes are
regulated in a rather cell-type specific manner.
Cluster analysis reveals functionally similar gene groups
in different cell types
We conducted a time series cluster analyses in order to find
groups of DE genes showing similar expression changes
Figure 1 Log2 fold-changes of 17 genes, which are DE in at least one cell type and are known to play a role in the TGF-β pathway
(according to KEGG annotation).
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shown in Additional file 1: Figures S3, between cell-types
similarities shown in Additional file 1: Figure S4). The
cluster analyses yielded 12 clusters in MPP and mouse
HPC, 20 in CDP and 11 in human MSC (Additional file 2:
Table S3). Genes contained in individual clusters can be
found in Additional file 2: Table S14. Figure 2 depicts the
mean curves for each of these clusters in each cell type. We
investigated the functional similarity of genes across differ-
ent clusters. For this purpose the R-Package “GOSemSim”
[32] utilizing the semantic similarity measure proposed by
Wang et al. [33] was employed. Semantic similarities are a
means to compare GO annotations of gene pairs in a quan-
titative manner, for example on the basis of the information
content of GO terms. We refer the reader to [34] for an
excellent overview.
A heatmap depicting these GO semantic similarities
suggested a high functional similarity of genes in several
clusters from different cell types (Additional file 1:
Figure S6 Additional file 2: Tables S15, S16). In particu-
lar cluster B (MPP), and cluster B (CDP) are highly simi-
lar to each other (semantic similarity > 0.7). Time-course
log2 fold changes of the corresponding genes are shown
in (Figure 3 top). As can be noticed the clusters are of
different size, but have several genes in common (13
genes). Functional analysis revealed that genes in these
clusters are enriched for cell adhesion molecules (CAMs),
valine, leucine and isoleucine biosynthesis, Pantothenateand CoA biosynthesis and regulation of cellular extrava-
sation. Enrichment analysis was conducted here via the
R-package GOstats [35], which employs a hypergeo-
metric test taking into account the dependency structure
among GO terms.
The second group of functionally similar clusters (Figure 3,
bottom) contains cluster K (human HPC) and cluster B
(MSCs). Genes in these clusters play (among others) a
role in TGF-β and Notch signaling pathways (Additional
file 2: Tables S15, S16).
Taken together our cluster analyses showed that des-
pite evident differences on the level of individual genes,
functionally similar clusters of genes can be identified
across cell types.
Enrichment analysis reveals commonly affected biological
processes, pathways and transcription factors in all cell types
Motivated by our previous findings we asked, whether there
were common functional patterns across all cell types. For
this purpose we scanned GO terms and KEGG pathways
for significant association with differential time course gene
expression in each cell type (Additional file 2: Tables S4,
S10, S11).
Our analysis brought up 6 KEGG pathways and 11 GO
terms, which were significantly associated to all cell types
(FDR < 5%, Figure 4). The 6 KEGG pathways associated
to all cell types were: Metabolic pathways, Glutathione
metabolism, Lysosome, Purine metabolism, Peroxisome
Figure 2 Cluster mean-curves of log2 fold changes for the different cell types. For mouse HPC no clusters could be identified and hence all
DE genes treated as one group.
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to all cells were: oxidation-reduction process, innate im-
mune response, positive regulation of transcription from
RNA polymerase II promoter, negative regulation of apop-
totic process, angiogenesis, lipid metabolic process, positive
regulation of cell proliferation, positive regulation of cell
migration, proteolysis, positive regulation of transcription
DNA-dependent and response to drug. The role of TGF-β
in apoptosis, cell proliferation as well as immune response
is well known. Moreover, an effect of TGF-β perturbation
on PPAR signaling has been described in skin fibroblasts
[36]. In [37] the authors describe TGF-β mediated oxida-
tive stress and decreased glutathione concentration in fi-
brosis models. Finally, there is evidence that TGF-β has an
effect on angiogensis and cell migration [38]. Hence, our
findings largely fit to the current biological knowledge
about TGF-β.
Conserved role of EGR1/2 transcription factors
We analyzed DE genes with respect to overrepresented
sequence motifs in their promoter regions with the
XXmotif tool [39]. Significant motifs were then com-
pared to known position weight matrices (TRANSFAC)
of transcription factors (TFs) via STAMP [40].
The analysis in each cell type predicted between 11 and
21 regulating TFBS in the time-course analysis (Additional
file 2: Tables S6, S17, S18), except for mouse HPC, where
no overrepresented TFBS could be detected. This may be
attributed to the small number of 16 DE genes in this celltype. Overlaps were particularly high within mouse MPP
and CDP and within human cells.
FOXP1, KROX, TEF, POU6F1, FOX and PITX binding
sites were commonly identified in mouse MPP and CDP.
KROX, HFH4 and PAX4 were found in all human cells.
FOX, FOXP1, KROX and TEF were found to be them-
selves representatives of DE genes. Figure 5 shows a net-
work representation of all eight TFBS together with the
set of DE genes containing respective binding sites. The
plot reveals a relative clear difference between mouse
and human cells with the exception of the KROX TFBS,
which appears in all four cell types. KROX represents
EGR1 and EGR2.
Network analysis suggests possible signal transduction
pathways in mouse and human
In order to better understand, how TGF-β may influence
the commonly identified transcription factor, biological
processes and the PPAR-pathway we conducted a network
analysis. Using protein-protein interaction information
from the BioGRID database [41] we reconstructed a
mouse and a human specific network depicting dys-
regulated paths from TGF-β to SKIL, SMAD7, EGR1 as
well as genes involved into glutathione metabolism, purine
metabolism, PPAR signaling, oxidation-reduction process,
innate immune response, negative regulation of apoptotic
process, angiogenesis, positive regulation of cell prolifera-
tion and positive regulation of cell migration (Figures 6
and 7; see further details in Methods part).
Figure 4 Clustered heatmaps of (a) the 6 common KEGG pathways and (b) 11 GO terms in different cell types. The color code indicates
the degree of association (−log(FDR)) of a KEGG pathway and GO term to each cell type, respectively.
Figure 3 Log2 fold changes of two groups of functionally similar clusters detected in different cell types. Genes appearing in more than
one cluster are depicted in color, gray curves are cluster-specific genes. Upper group: two similar clusters MPP and CDP. Lower group: two similar
clusters in human HPC and MSC.
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Figure 5 Network of eight overrepresented TFBS and DE genes containing these binding sites. For the sake of better visualization only
the set of genes being DE in both, HPC and MSC as well as both, MPP and CDP, are shown. Red genes are known to play role in the TGF-β
pathway. The width of the blue lines is chosen to be proportional to the average –log E-value, which resulted from the XXmotif analysis.
Figure 6 Human protein-protein interaction network connecting TGFB1, TGFBR1, SMAD7, SKIL, EGR1, PPARG with genes involved into
commonly identified biological processes and pathways. The dashed green line indicates the putative transcriptional regulation of SMAD7 by
transcription factor EGR1. The darker the red color of a node the higher the average probability for differential time course expression.
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Figure 7 Murine protein-protein interaction network connecting Tgbfr1, Smad7, Skil, Egr1, Pparg with genes involved into commonly
identified biological processes and pathways. The dashed green line indicates the putative transcriptional regulation of Smad7 and Tgfbr1 by
transcription factor Egr1. The darker the red color of a node the higher the average probability for differential time course expression.
Figure 8 Percentages of KEGG pathways (left) and GO terms
(right) enriched commonly in our cell types that could be
reproducibly identified in GSE17708. The numbers in tip of the
bars are the p-value for the null-hypothesis to see the corresponding
overlap just by chance (hyper-geometric test).
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stimulation is possibly propagated via protein-protein inter-
actions to our commonly identified biological processes.
Due to the organism specificity of interactome information
these pathways show certain differences: Far less protein-
protein interactions are known in mouse than in human. In
human, for example, negative regulation of apoptosis might
be mediated via SMAD3 and SOX9 [42]. In contrast, the
GO and network analysis in mouse suggests a direct
role of TGFBR1.
Enrichment of biological processes, pathways and tfbss is
reproducible on independent dataset
To validate the central finding from our data, namely
the existence of commonly affected biological processes,
pathways and transcription factors in all cell types, we
downloaded an independent dataset comprising gene ex-
pression data measured at 9 time points (0, 0.5, 1, 2, 4,
8, 16, 24, 72 h) after TGF-β stimulation in human A549
lung adenocarcinoma cell-lines (CRL, GSE17708). The
dataset was analyzed in the same manner as described
for our data before. High fractions of the 11 GO terms
and 6 KEGG pathways commonly identified in all of
our cell types were also found in GSE17708 (Figure 8,
Additional file 2: Table S10). Out of the KEGG pathways
and GO terms associated to all of our human cells 70%
and 74%, respectively could be reproduced on the inde-
pendent dataset (Figure 8, Additional file 2: Table S11).
Notably, 11 (61%) out of the 18 genes which exhibitingdifferential time courses in both our human MSC and
HPC cells were found also to have differential time-
courses in GSE17708 cells, these were ROR1, SMAD7,
FSTL3, GADD45B, JUNB, ZFP36, ID1, LMCD1, GXYLT2,
SKIL and HES1. This corresponding fraction is signifi-
cantly larger than expected by chance (p < 1E-9, hyper-
geometric test).
The KROX TFBS (corresponding to TFs EGR1 and
EGR2), which was enriched in all of our cell types, was
also found in GSE17708. Moreover, the other two TFBS
that we identified in our human cells (HFH4, PAX4)
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(Additional file 2: Tables S17).
Taken together this analysis reveals a high reproduci-
bility of our commonly identified biological processes,
pathways as well as TFs.
Conclusions
We have conducted an in-depth comparison of the dy-
namical TGF-β1 response profile on gene expression
level across several cell types. Despite of a generally high
degree of cell type specificity, there appears to be a com-
mon functional response, which is conserved across
cell types and species (i.e. mouse and human). Our ana-
lysis suggests a common effect of TGF-β1 stimulation
on apoptosis, cell proliferation, immune response, angio-
genesis, cell migration, PPAR signaling, oxidative stress
as well as purine and glutathione metabolism. Network
analysis gives hints to possible pathways, by which these
effects could be mediated.
On the level of individual genes the SKI-like oncogene
and Smad7 were differentially expressed in most (Smad7)
or all (SKI-like oncogene) cell types and thus appear to
play a major role. Smad7 is involved into the canonical
TGF-β pathway [43]. It is a general antagonist of the
TGF-β family (for review see [44]). The SKI-like onco-
gene is a direct target gene of Smad2, which regulates
its transcription [45]. It plays a role in cell growth and
differentiation.
Notably, a high fraction of the biological processes,
pathways and TFBS that we identified to be enriched in
all our cell types was found also in an independent data-
set from a lung cancer cell line. This strengthens the
confidence into our results.
In summary our findings indicate that despite a high
variability of transcriptional response across cell types
and organisms there appears to be a set of commonly af-
fected processes and pathways. In addition, the TFBS
analysis suggested a major role of the transcription fac-
tor EGR1 in the TGF-β response in human and mouse.
Indeed the induction of EGR1 via TGF-β stimulation
has been already reported earlier [46] and thus fits to
the existing knowledge about TGF-β1 − induced tran-
scriptional response in other cell systems.
Previous studies of TGF-β stimulation were mainly
limited to one specific cell type (e.g. fibroblasts). In this
paper we went beyond this point and conducted experi-
ments in different cell types under as much as possible
comparable conditions. In consequence we were able to
compare transcriptional responses across cell types and
organisms, which revealed common patterns. The iden-
tification of common and specific signal transduction
pathways that are affected by TGF-β in human and mice
will allow us to define potential therapeutic targets and
will further enable us to characterize gene expressionpatterns and complex regulatory networks. In addition,
future work using our and other transcriptome data can,
for example, address the identification of TGF-β
dependent mesenchymal or epithelial gene signatures or
the definition of cell specific cancer signatures.
Methods
Ethics statement
Animal experiments required for obtaining murine
MPP, CDP and HPC were approved by local authorities
(Landesamt für Natur, Umwelt und Verbraucherschutz
Nordrhein-Westfalen - LANUV NRW) in compliance
with the German animal protection law. Experiments
were performed at the Institute for Animal Research of
the RWTH Aachen University Hospital, under projects
10534A4 and 10718A4, entitled “Untersuchungen zur
Hämatopoese aus adulten Blutstammzellen”. Animal main-
tenance, handling, and anesthesia were performed accord-
ing to the Federation for Laboratory Animal Science
Associations FELASA recommendations.
All samples of human MSC cells were used after patient’s
written consent using guidelines approved by the Ethic
Committee of the RWTH University of Aachen (Permit
number: EK128/09).
Mouse hematopoietic progenitor cells (MPP & CDP)
Cell culture
MPP and CDP were obtained from mouse bone marrow,
using in vitro culture with a specific cytokine cocktail
and FACS sorting [12,13].
TGF-β1 stimulation
After sorting, MPP and CDP were treated with 10 ng/
mL recombinant human TGF-β1 (R&D Systems, Minne-
apolis, USA) for 2, 4, 8, 12 and 24 h as described in [12]
or left untreated. Cells were lysed in 350 μl TRI-Reagent
and stored at −80°C.
RNA isolation
RNA was isolated using the MagMAX-96 for Microar-
rays kit (Life Technologies, Darmstadt, Germany) ac-
cording to manufacturer’s protocol.
Primary mouse hepatocytes and human HepG2 cells (HPC)
Hepatocytes (HPC) represent the most prominent cell
population in the liver. Primary HPC are sensitive to
TGF-β1, and express the corresponding type I (ALK5),
type II (TβRII), and type III (betaglycan) receptors. TGF-
β1 promotes cell cycle arrest and apoptosis of primary
HPC. In addition, in vitro TGF-β1 provokes epithelial-to-
mesenchymal transition (EMT)-like processes in this hep-
atic cell subpopulation, which most likely do not occur
in vivo [47].
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primary hepatoblastoma [48]. They do secrete the major
plasma proteins but do not express the hepatitis B virus
surface antigen (HBsAg) [49].
Cell culture
Primary murine HPC were isolated from male C57BL/6
mice according to the collagenase method of Seglen
[50]. Cells were plated in collagen coated 6-well dishes
at a density of 1.2 × 106 cells using HepatoZYME-SFM
(Gibco, Life Technology, Darmstadt, Germany). Four
hours after seeding the medium was renewed and cells
were grown for a further 24 hrs culture period.
HepG2 (DSMZ: DSM ACC180) were cultured in RPMI
(PAA, Pasching, Austria) containing 10% fetal calf serum
(PAA), 1 × Penicillin/Streptomycin (Lonza, Cologne,
Germany). Medium was renewed every second day. For
the experiment, cells were passaged and plated in 6-well
dishes using accutase (PAA) at a density of 4 × 105 cells.
One day before the experiment, cells were washed with
PBS (1×), medium changed to HepatoZYME-SFM (Gibco)
and cultured for further 24 hrs.
TGF-β1 stimulation
One hour before the experiment, the medium was ex-
changed and cells stimulated with 1 ng/mL recombin-
ant human TGF-β1 (R&D Systems, Minneapolis, USA)
for indicated time intervals (HepG2: 0 min, 20 min,
1 h, 2 h, 4 h, 24 h; murine HPC: 0 min, 1 h, 2 h, 4 h).
The cells were harvested using Qiazol for cell lysis
(Qiagen, Hilden, Germany), directly frozen and stored
at −80°C.
RNA isolation
RNA was isolated using the RNeasy Kit system (Qiagen),
performing a DNAse digestion according to the manu-
facturer’s protocol.
Human Mesenchymal Stromal Cells (MSC)
Mesenchymal stromal cells (MSC) are found in all sup-
portive tissue as in fat tissue, bone marrow and cord.
MSC are characterized by their plastic adherence and
their differentiation potential towards adipogenic, osteo-
genic and chondrogenic lineages. All MSC express the
surface markers CD29, CD73, CD90 and CD105 and
they lack the expression of CD14, CD31, CD34 and
CD45 [14,51].
Isolation and expansion
MSCs were isolated from mononuclear cells (MNCs) by
plastic adherence as described before [16,52,53]. In brief,
bone fragments from the caput femoris of patients
undergoing femoral head prosthesis were flushed with
phosphate- buffered saline (PBS) and washed twice withPBS. MNC were then resuspended in culture medium
and seeded into tissue culture flasks. Cells were cultured
at 37°C in a humidified atmosphere with 5% CO2. The
first medium exchange was performed after 48 h to re-
move nonadherent cells. Thereafter, media changes were
performed twice per week and MSCs were passaged
when reaching 80-90% of confluence.
TGF-β1 stimulation
MSC from three different donors were used in an early
passage (p3-5) for stimulation with TGF-b1. 1x106 MSC
were seeded into 6-well culture plates. When the cells
were attached after 24 h 1 ng/mL recombinant TGF-β1
(R&D Systems) was added to the culture media at differ-
ent time points. The cells were harvested at the same
time point with Qiazol (Qiagen) and directly frozen and
stored at −80°C.
RNA isolation
RNA was isolated via phenol/chloroform extraction
using the miRNeasy Kit (Qiagen), performing a DNAse
digestion.
Genechip hybridization
Human samples were assayed using Affymetrix Gene-
Chip® type “Human Gene 1.0 ST Array” with 34,760
probe-sets and mouse samples were assayed in Affyme-
trix GeneChip type “Mouse Gene 1.0 ST Array” with
32,321 probe-sets. Hybridization, wash and staining were
done according to manufacturer’s recommended stand-
ard techniques.
Normalization and preprocessing
Raw probe intensities were normalized and summarized to
expression levels using the FARMS algorithm which uti-
lizes a factor analysis approach [54]. A rigorous quality as-
sessment confirmed a fairly good quality of the chips with
exception of mouse HPC chips where Initial chip quality
assessment revealed a strong batch effect and one bad chip
(replicate no. 1 at time 1 hour). The bad chip was excluded
and batch adjustment was performed to alleviate that effect
on those chips via the “ComBat” method [55].
Affymetrix probe IDs were mapped to Entrez gene IDs
using the Bioconductor annotation packages “mogen-
e10sttranscriptcluster.db” in mouse chips and “hugen-
e10sttranscriptcluster.db” in human chips [56,57].
Differential gene expression
Time point specific analysis
Differential gene expression analyses via “Limma” Linear
Models for Microarray Data [58] using empirical Bayes
method [59] was performed by comparing samples at
each time point after TGF-β stimulation to the unstimu-
lated cells at time point 0. Statistical dependencies of
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ered via a factorial design matrix in “Limma” using a
“time” and a “replicate” factor, and contrasts are consid-
ered for interaction effects. Corrections for multiple test-
ing was done using the Benjamini & Hochberg’s method
[60]. Significant differentially expressed genes are con-
sidered those with FDRBH < 0.01 and absolute log2 fold
change value (logFC) ≥ 1.
Analysis of whole time courses
The small number of replicates in our experiments limits
the power of statistical testing procedures for assessing
differential gene expression at individual time points. Fur-
thermore, the number of measured time points is not the
same for each cell type, which complicates any further
meta-analysis. Therefore, we employed the “betr” method
to analyze whole time series at once [27]. The algorithm
of this method uses a random-effects model together with
the empirical Bayes method to estimate probabilities for
differential expression of whole time courses. Genes were
considered to be significant at a probability cutoff of >
99% for the whole time-course analysis and absolute log2
fold change (logFC) ≥ 1. Since “betr” requires the same
number of replicates per time point and one chip in
mouse HPC had to be omitted due to low quality (see
Normalization & Preprocessing) unfortunately in this par-
ticular cell line we had to exclude time point 1 h com-
pletely from the time-course analysis.
Cluster analysis
Clustering of gene expression time series was done via the
MFDA method proposed in [61]. The method assumes
gene expression time series within each given cluster to
follow a mean curve plus some Gaussian noise. It decides
cluster allocation via a Gaussian Mixture Model utilizing
an EM algorithm for parameter estimation and decides
the optimal number of clusters via the Bayesian Informa-
tion Criterion (BIC).
It is worth mentioning that we applied MFDA not on
raw gene expression data here, but on log fold-changes
relative to time point 0. The reason was that we wanted
to group genes not on the basis of their absolute expres-
sion values, but on the basis of similar response to the
stimulus.
KEGG and go analysis
Analyses of pathways in KEGG [43] and biological pro-
cesses in Gene Ontology project (GO) [62] were per-
formed as follows: The –log(p-value) of all genes in the
individual time point analysis and –log(1 – probabilities)
of all genes in the whole time-course analysis, respect-
ively, were taken as a ranking score for each transcript.
Gene sets of KEGG pathways and GO terms were then
tested for their association with these ranking scores viaa univariate logistic regression based test [63,64]. Result-
ing p-values of KEGG pathways and GO terms were
adjusted according to Benjamini & Yekutieli’s false dis-
covery rate control under dependency [65], and signifi-
cant KEGG pathways and GO terms reported at a
FDRBY cutoff value of 5%.Transcription factor binding sites analysis
Analysis of transcription factors binding sites (TFBSs)
was performed using the de novo sequence motif detec-
tion method XXmotifs [39]. Identified sequence motifs
were then aligned to known TRANSFAC TFBS via
STAMP [66] and the top match is considered. The
XXmotif method uses BLAST [67] all-against-all com-
parisons to mask regions of local homology in order to
avoid false positives. The method then performs an
enrichment analysis after transforming the found pat-
terns to position weight matrices (PWMs). The STAMP
method utilizes a global or un-gapped local alignment to
detect DNA motifs similarities to defined PWMs. Fur-
thermore, it considers familial binding profiles, thus im-
proving transcription factors (TF) classification accuracy.
TFBSs analysis was done using these methods in each
cell type for those genes, which according to the time-
course analysis showed a probability of > 0.99% for dif-
ferential expression. Promoter sequences of the genes
under consideration (2Kbp upstream of transcription
start site) were obtained from the Ensembl database [68]
via “biomaRt” [69,70]. Only the top matching motif for
each TRANSFAC TFBS was considered and significant
TFBSs were reported at an E-Value threshold of 1e-3.
Mapping of TFBS to individual transcription factors was
performed via manual inspection of TRANSFAC PWMs.
We obtained all proteins which had been used to con-
struct each of the PWMs. With the help of the commer-
cial software GeneGo Metacore® [71] we then mapped
protein names to Entrez gene IDs. As a consequence we
found for the TFBS FOXP1 the differentially expressed
genes Foxp2 and FoxP1 (MPP, CDP mouse cells). For the
TFBS FOX the human gene FAU was identified (human
HPC). For KROX we found Egr1/EGR1 (mouse HPC, hu-
man MSC) and EGR2 (human MSC). For TEF we identi-
fied Klf3/KLF3 (MPPs, CDPs, and human HPC), TRIM37
and USP7 (human HPC, MSC).Identification of homologous genes
Human homologs of mouse genes were identified via the
KEGG Sequence Similarity Data Base (SSDB), which
contains local alignments of amino acid sequences for
protein coding genes from different species. We here
considered two genes to be homologs, if the alignment
E-value was below 1e-30 (bit-score > 112). In case of
more than one homologous gene, all are considered.
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Information about protein-protein interactions was col-
lected separately for human and mouse from the BioGRID
database version 3.2.109 [41]. Correspondingly, a network
comprising 16,011 nodes and 140,471 physical interactions
was constructed for human. For mouse the network con-
sisted of 6,233 nodes and 16,100 physical interactions.
Nodes in these networks were weighted by the average
probability (mean over all cell types from the same organ-
ism) for differential time course expression according to
the betr model (see above). A “distance” for each edge
was then calculated as 2 minus the sum of its incident
nodes’ weights. Hence: the smaller the distance the higher
the weight of its incident nodes. We used Dijkstra’s algo-
rithm to search for minimum distance (i.e. maximum node
weight) path connecting TGFB1 with each of SKIL,
SMAD7, EGR1, PPARG and all genes annotated to gluta-
thione metabolism, purine metabolism, oxidation-reduction
process, innate immune response, negative regulation of
apoptotic process, angiogenesis, positive regulation of cell
proliferation and positive regulation of cell migration. For
each of the last mentioned terms we only kept those genes
as representatives which showed the minimum distance to
TGFB1. If there were several paths of the same minimum
distance, all of them were considered.
In the network for mouse Tgfb1 was not identified and
hence we started our analysis with Tgfbr1 instead.Availability of supporting data
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